VASCULAR ADHESIVE MOLECULES AND MODULATION OF THEIR FUNCTIONS Russian patent published in 2005 - IPC

Abstract RU 2244748 C2

FIELD: biotechnology, medicine, proteins.

SUBSTANCE: invention describes new polypeptide in isolated form relating to subfamily of superfamily human immunoglobulins (Ig-Sf). This polypeptide shows at least 70% of homology level with amino acid sequence of murine molecules CRAM-1 or CRAM-2 regulated by the confluence of adhesive (figures 3, 6 are represented in the claim). Also, invention relates to antibodies showing specificity with respect to the polypeptide. Antibodies and soluble polypeptide can be used for treatment of inflammation and tumors. Invention describes polynucleotide or oligonucleotide encoding the full-size polypeptide or its moiety and represents primer, probe, anti-sense RNA and shows the nucleotide sequence that is identical conceptually with human CRAM-1. Invention provides preparing new adhesive proteins from superfamily Ig-Sf that are regulated at the transcription level in endothelium by effect of tumors. Invention can be used for treatment of different diseases, in particular, inflammatory responses.

EFFECT: valuable medicinal properties of polypeptide.

19 cl, 33 dwg, 1 ex

Similar patents RU2244748C2

Title Year Author Number
VASCULAR ADHESION PROTEIN-1 OF AMINOOXIDASE ACTIVITY 1998
  • Jalkanen Sirpa
  • Salmi Marko
  • Smit Dehjvid Dzhon
  • Bono Petri
RU2204838C2
NEW ISOFORMS OF VASCULAR ENDOTHELIAL CELL GROWTH INHIBITOR 2002
  • Li Lujuan
  • Pan Khongguang
RU2316591C2
ISOLATED NUCLEIC ACID MOLECULE ENCODING CHIMERIC TIE-2-LIGAND (VARIANTS), CHIMERIC OR MODIFIED TIE-2-LIGAND AND METHOD FOR ITS PREPARING, VECTOR, METHOD FOR PREPARING SYSTEM VECTOR-HOST, CONJUGATE, PHARMACEUTICAL COMPOSITION 1997
  • Dehvis Sehmjuel'
  • Jankopoulos Dzhordzh D.
RU2233880C2
VIRAL VECTOR MANUFACTURE 2014
  • Khauli Pol Majkl
  • Lyu Lyan
RU2658487C2
MODIFIED ANTAGONISTIC ANTIBODY 2001
  • Fukusima Naosi
  • Tsutija Masajuki
  • Uno Sinsuke
  • Okhtomo Tosikhiko
  • Jabuta Naokhiro
  • Tsunoda Khirojuki
RU2295537C2
APPLICATION OF FUSED POLYPEPTIDE CONTAINING MeCP2 PROTEIN AND PROTEIN TRANSDUCTION DOMAIN, PHARMACEUTICAL COMPOSITION CONTAINING SUCH PROTEIN AND METHOD OF TREATING AND/OR PREVENTING DEVELOPMENTARY NEUROPATHY 2006
  • Lakkone Franko Antonio
RU2432359C2
LINE OF CELLS CHO[V3D], SECRETING RECOMBINANT VESSEL ENDOTHELIUM GROWTH FACTOR (VEGF) OF HUMANS, ISOFORM A165, WITH EXOGENIC 3×DED-EPITOPE 2012
  • Vikhreva Polina Nikitichna
  • Lysjuk Elena Jur'Evna
  • Lukashina Marina Igorevna
  • Gnuchev Nikolaj Vasil'Evich
  • Larin Sergej Sergeevich
  • Korobko Elena Vladimirovna
  • Korobko Igor' Viktorovich
RU2493251C1
DEGRADED ANTIBODY AS TPO AGONIST 2001
  • Tsutija Masajuki
  • Okhtomo Tosikhiko
  • Jabuta Naokhiro
  • Tsunoda Khirojuki
  • Orita Tetsuro
RU2287534C2
DPPIV-COGNATED NEW SERINE PROTEASE GENE 2001
  • Ki Stiv
  • Akinsan'Ja Karen O.
  • Riv'Er P'Er Zh.-M.
  • Zhjun'En Zhan-Lui
RU2305133C2
PSCAXCD3, CD19XCD3, C-METXCD3, ENDOSIALIN XCD3, EPCAMXCD3, IGF-1RXCD3 OR FAP-ALPHA XCD3 BISPECIFIC SINGLE-CHAIN ANTIBODY WITH INTER-SPECIES SPECIFICITY 2009
  • Kufer,Peter
  • Raum,Tobias
  • Kischel,Roman
  • Lutterbuse,Ralf
  • Hoffmann,Patrick
  • Rau,Doris
  • Klinger,Matthias
  • Mangold,Susanne
  • Blumel,Claudia
RU2547600C2

RU 2 244 748 C2

Authors

Imkhof Beat Al'Bert

Orran-Lion Mishel'

Dates

2005-01-20Published

2000-03-13Filed